News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

HK data: SGLT2 inhibitors cut risks of respiratory and renal diseases in T2DM
29 Mar 2023
byKanas Chan
Sodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risks of respiratory and renal diseases vs dipeptidyl peptidase-4 (DPP-4) inhibitors in patients with type 2 diabetes mellitus (T2DM), researchers from the University of Hong Kong (HKU) have reported.
29 Mar 2023







